Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cell Nucleus | 35 | 2024 | 602 | 7.370 |
Why?
|
Cell Nucleolus | 26 | 2023 | 68 | 6.760 |
Why?
|
Cell Biology | 10 | 2024 | 21 | 6.400 |
Why?
|
History, 20th Century | 43 | 2024 | 226 | 5.460 |
Why?
|
Molecular Biology | 12 | 2020 | 67 | 4.710 |
Why?
|
History, 21st Century | 31 | 2024 | 161 | 4.260 |
Why?
|
RNA | 19 | 2021 | 402 | 3.410 |
Why?
|
Genome | 9 | 2022 | 252 | 3.100 |
Why?
|
Science | 5 | 2022 | 33 | 3.040 |
Why?
|
RNA, Messenger | 19 | 2021 | 1466 | 2.850 |
Why?
|
Humans | 134 | 2024 | 59081 | 2.690 |
Why?
|
Periodicals as Topic | 7 | 2022 | 170 | 2.650 |
Why?
|
Genome, Human | 6 | 2020 | 218 | 2.450 |
Why?
|
Microscopy, Fluorescence | 9 | 2020 | 398 | 2.320 |
Why?
|
Ribosomes | 12 | 2019 | 153 | 2.300 |
Why?
|
Cell Cycle | 9 | 2019 | 378 | 2.300 |
Why?
|
Nobel Prize | 7 | 2024 | 11 | 2.290 |
Why?
|
Biochemistry | 5 | 2021 | 50 | 2.120 |
Why?
|
Chromosomes, Human | 4 | 2019 | 53 | 1.960 |
Why?
|
Biology | 4 | 2022 | 25 | 1.920 |
Why?
|
DNA | 9 | 2022 | 787 | 1.870 |
Why?
|
Research | 5 | 2021 | 190 | 1.870 |
Why?
|
DNA Repair | 6 | 2022 | 226 | 1.860 |
Why?
|
Publications | 4 | 2019 | 28 | 1.850 |
Why?
|
Terminology as Topic | 3 | 2020 | 138 | 1.710 |
Why?
|
Nuclear Proteins | 13 | 2018 | 759 | 1.710 |
Why?
|
Genomics | 4 | 2022 | 313 | 1.690 |
Why?
|
Fluorescent Dyes | 6 | 2020 | 195 | 1.640 |
Why?
|
Genetics, Medical | 2 | 2022 | 11 | 1.620 |
Why?
|
Animals | 64 | 2024 | 19554 | 1.600 |
Why?
|
Neoplasms | 6 | 2019 | 1224 | 1.580 |
Why?
|
Clustered Regularly Interspaced Short Palindromic Repeats | 3 | 2017 | 84 | 1.470 |
Why?
|
Women's Health Services | 2 | 2023 | 31 | 1.450 |
Why?
|
Signal Recognition Particle | 9 | 2011 | 38 | 1.450 |
Why?
|
Biomedical Research | 3 | 2018 | 247 | 1.390 |
Why?
|
Publishing | 3 | 2020 | 89 | 1.350 |
Why?
|
Drug Industry | 2 | 2021 | 40 | 1.330 |
Why?
|
Chromosomes | 5 | 2022 | 133 | 1.330 |
Why?
|
Biological Evolution | 3 | 2022 | 109 | 1.270 |
Why?
|
RNA, Transfer | 6 | 2016 | 76 | 1.260 |
Why?
|
Carrier Proteins | 5 | 2022 | 714 | 1.230 |
Why?
|
Women's Health | 3 | 2021 | 390 | 1.220 |
Why?
|
RNA, Ribosomal | 10 | 2014 | 53 | 1.220 |
Why?
|
United States | 22 | 2024 | 7461 | 1.210 |
Why?
|
Protein Biosynthesis | 7 | 2016 | 291 | 1.210 |
Why?
|
Portraits as Topic | 7 | 2022 | 13 | 1.200 |
Why?
|
Cardiology | 2 | 2020 | 164 | 1.200 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2021 | 111 | 1.190 |
Why?
|
Research Personnel | 4 | 2020 | 85 | 1.190 |
Why?
|
Transcription, Genetic | 9 | 2022 | 847 | 1.150 |
Why?
|
Artificial Intelligence | 2 | 2021 | 162 | 1.080 |
Why?
|
MicroRNAs | 6 | 2016 | 617 | 1.080 |
Why?
|
In Situ Hybridization | 8 | 2019 | 215 | 1.030 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 1536 | 1.030 |
Why?
|
Physicians | 2 | 2020 | 429 | 0.990 |
Why?
|
Schizophrenia | 2 | 2018 | 256 | 0.980 |
Why?
|
Osteosarcoma | 2 | 2019 | 53 | 0.930 |
Why?
|
Chromatin | 10 | 2020 | 591 | 0.930 |
Why?
|
Scientific Misconduct | 2 | 2019 | 11 | 0.930 |
Why?
|
Congresses as Topic | 2 | 2024 | 71 | 0.910 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 2 | 2022 | 43 | 0.900 |
Why?
|
Politics | 2 | 2021 | 30 | 0.900 |
Why?
|
Research Support as Topic | 3 | 2019 | 43 | 0.900 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2014 | 75 | 0.890 |
Why?
|
CRISPR-Cas Systems | 2 | 2018 | 321 | 0.890 |
Why?
|
Patents as Topic | 2 | 2021 | 6 | 0.890 |
Why?
|
Reproductive Health Services | 1 | 2023 | 12 | 0.880 |
Why?
|
Drug Discovery | 2 | 2021 | 91 | 0.870 |
Why?
|
Staining and Labeling | 4 | 2016 | 123 | 0.870 |
Why?
|
Peer Review, Research | 3 | 2020 | 46 | 0.850 |
Why?
|
Transcriptional Activation | 2 | 2014 | 188 | 0.850 |
Why?
|
Famous Persons | 2 | 2016 | 8 | 0.840 |
Why?
|
Mitosis | 3 | 2019 | 207 | 0.830 |
Why?
|
Vaccination | 2 | 2022 | 333 | 0.820 |
Why?
|
Laboratory Personnel | 1 | 2022 | 3 | 0.800 |
Why?
|
Mass Media | 1 | 2022 | 30 | 0.780 |
Why?
|
Heredity | 2 | 2024 | 7 | 0.780 |
Why?
|
Spliceosomes | 2 | 2017 | 41 | 0.770 |
Why?
|
Centrioles | 2 | 2020 | 26 | 0.770 |
Why?
|
Actins | 5 | 2013 | 259 | 0.760 |
Why?
|
Awards and Prizes | 1 | 2021 | 30 | 0.750 |
Why?
|
Knowledge | 1 | 2021 | 30 | 0.750 |
Why?
|
Life Expectancy | 1 | 2021 | 32 | 0.750 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 130 | 0.740 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2022 | 418 | 0.730 |
Why?
|
Gender Identity | 1 | 2021 | 60 | 0.730 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 20 | 0.730 |
Why?
|
Cytological Techniques | 2 | 2019 | 23 | 0.720 |
Why?
|
Biological Products | 1 | 2022 | 93 | 0.720 |
Why?
|
Rats | 18 | 2020 | 1904 | 0.720 |
Why?
|
Cytoplasm | 5 | 2014 | 270 | 0.720 |
Why?
|
RNA Splicing | 3 | 2017 | 161 | 0.720 |
Why?
|
Transfection | 4 | 2020 | 671 | 0.710 |
Why?
|
Vaccines, Synthetic | 1 | 2020 | 68 | 0.710 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2020 | 22 | 0.710 |
Why?
|
Human Genetics | 1 | 2020 | 2 | 0.710 |
Why?
|
Longevity | 1 | 2021 | 111 | 0.700 |
Why?
|
Drug Repositioning | 1 | 2020 | 6 | 0.690 |
Why?
|
Racism | 1 | 2021 | 79 | 0.690 |
Why?
|
Medical Writing | 1 | 2019 | 2 | 0.680 |
Why?
|
Pandemics | 2 | 2022 | 603 | 0.680 |
Why?
|
Theft | 1 | 2019 | 3 | 0.670 |
Why?
|
Intellectual Property | 1 | 2019 | 6 | 0.670 |
Why?
|
Vaccines | 1 | 2021 | 96 | 0.670 |
Why?
|
Financial Management | 1 | 2019 | 5 | 0.660 |
Why?
|
Homeostasis | 1 | 2022 | 340 | 0.660 |
Why?
|
Fees and Charges | 1 | 2019 | 18 | 0.660 |
Why?
|
Societies | 1 | 2019 | 21 | 0.650 |
Why?
|
Protein Folding | 1 | 2021 | 256 | 0.650 |
Why?
|
Genetics | 2 | 2018 | 13 | 0.650 |
Why?
|
Myoblasts | 4 | 2014 | 63 | 0.650 |
Why?
|
Education, Graduate | 1 | 2019 | 14 | 0.650 |
Why?
|
Phage Therapy | 1 | 2019 | 1 | 0.650 |
Why?
|
Biological Science Disciplines | 1 | 2019 | 6 | 0.650 |
Why?
|
Public Health | 1 | 2020 | 180 | 0.640 |
Why?
|
tau Proteins | 1 | 2019 | 103 | 0.640 |
Why?
|
Anxiety Disorders | 1 | 2020 | 188 | 0.630 |
Why?
|
Cell Cycle Proteins | 2 | 2013 | 374 | 0.630 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 350 | 0.620 |
Why?
|
RNA Interference | 2 | 2017 | 588 | 0.620 |
Why?
|
Schools | 1 | 2019 | 156 | 0.620 |
Why?
|
Cobalt | 1 | 2018 | 16 | 0.620 |
Why?
|
RNA Precursors | 6 | 2013 | 74 | 0.620 |
Why?
|
Hematology | 1 | 2018 | 11 | 0.620 |
Why?
|
Sex Factors | 1 | 2021 | 957 | 0.610 |
Why?
|
History, 19th Century | 5 | 2021 | 42 | 0.610 |
Why?
|
Betacoronavirus | 1 | 2020 | 159 | 0.610 |
Why?
|
Foundations | 1 | 2018 | 8 | 0.610 |
Why?
|
Molecular Imaging | 1 | 2018 | 47 | 0.610 |
Why?
|
Mentoring | 1 | 2019 | 48 | 0.600 |
Why?
|
Cell Physiological Phenomena | 2 | 2016 | 12 | 0.600 |
Why?
|
Protein Conformation | 1 | 2021 | 762 | 0.600 |
Why?
|
Ribosomal Proteins | 5 | 2014 | 41 | 0.600 |
Why?
|
Reproductive Medicine | 1 | 2017 | 5 | 0.600 |
Why?
|
Bacteriophages | 1 | 2019 | 46 | 0.600 |
Why?
|
Viruses | 1 | 2019 | 79 | 0.600 |
Why?
|
Malaria | 1 | 2019 | 101 | 0.590 |
Why?
|
Fertilization in Vitro | 1 | 2018 | 90 | 0.590 |
Why?
|
Disease | 1 | 2017 | 26 | 0.590 |
Why?
|
Hemoglobinopathies | 1 | 2017 | 5 | 0.590 |
Why?
|
Aromatase | 1 | 2017 | 16 | 0.590 |
Why?
|
Contraceptive Agents, Female | 1 | 2018 | 24 | 0.590 |
Why?
|
Biophysical Phenomena | 2 | 2015 | 21 | 0.580 |
Why?
|
Evolution, Molecular | 3 | 2010 | 292 | 0.580 |
Why?
|
Cells | 2 | 2016 | 30 | 0.580 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2008 | 299 | 0.580 |
Why?
|
Gastric Acid | 1 | 2017 | 10 | 0.580 |
Why?
|
Pharmaceutical Services | 1 | 2017 | 31 | 0.580 |
Why?
|
DNA Restriction Enzymes | 2 | 2017 | 35 | 0.580 |
Why?
|
Drug Costs | 1 | 2017 | 58 | 0.580 |
Why?
|
Clinical Laboratory Techniques | 1 | 2017 | 44 | 0.580 |
Why?
|
Bacterial Infections | 1 | 2019 | 139 | 0.570 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2018 | 88 | 0.570 |
Why?
|
Introns | 1 | 2017 | 106 | 0.570 |
Why?
|
Antacids | 1 | 2017 | 13 | 0.570 |
Why?
|
Cooperative Behavior | 1 | 2019 | 217 | 0.570 |
Why?
|
Coronavirus Infections | 1 | 2020 | 186 | 0.560 |
Why?
|
Students | 1 | 2019 | 207 | 0.560 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 198 | 0.560 |
Why?
|
Ecology | 1 | 2016 | 12 | 0.560 |
Why?
|
Chemistry, Bioinorganic | 1 | 2016 | 2 | 0.560 |
Why?
|
Embryology | 1 | 2016 | 3 | 0.550 |
Why?
|
Physics | 1 | 2016 | 12 | 0.550 |
Why?
|
Academies and Institutes | 1 | 2016 | 22 | 0.550 |
Why?
|
Eukaryotic Cells | 2 | 2014 | 55 | 0.550 |
Why?
|
Academic Medical Centers | 2 | 2017 | 312 | 0.550 |
Why?
|
Proteins | 2 | 2021 | 742 | 0.540 |
Why?
|
RNA, Untranslated | 3 | 2017 | 101 | 0.530 |
Why?
|
Pharmaceutical Preparations | 1 | 2017 | 121 | 0.530 |
Why?
|
Inheritance Patterns | 1 | 2016 | 18 | 0.530 |
Why?
|
Developmental Biology | 1 | 2016 | 6 | 0.530 |
Why?
|
Signal Transduction | 3 | 2022 | 2883 | 0.520 |
Why?
|
Public Policy | 1 | 2016 | 41 | 0.520 |
Why?
|
Glycolysis | 1 | 2016 | 54 | 0.520 |
Why?
|
Bacteria | 1 | 2019 | 275 | 0.520 |
Why?
|
Influenza, Human | 1 | 2018 | 193 | 0.510 |
Why?
|
Caenorhabditis elegans | 1 | 2022 | 617 | 0.510 |
Why?
|
Endonucleases | 1 | 2016 | 81 | 0.510 |
Why?
|
Genes | 1 | 2015 | 96 | 0.510 |
Why?
|
Psychotic Disorders | 1 | 2017 | 150 | 0.500 |
Why?
|
Gonadal Steroid Hormones | 1 | 2015 | 32 | 0.490 |
Why?
|
Curriculum | 1 | 2019 | 543 | 0.490 |
Why?
|
Chemistry | 1 | 2015 | 30 | 0.490 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 455 | 0.490 |
Why?
|
Heart Diseases | 1 | 2017 | 204 | 0.480 |
Why?
|
Virus Replication | 2 | 2020 | 302 | 0.480 |
Why?
|
Biophysics | 1 | 2014 | 42 | 0.480 |
Why?
|
Tritium | 2 | 2014 | 21 | 0.480 |
Why?
|
Thymidine | 2 | 2014 | 25 | 0.480 |
Why?
|
Models, Biological | 3 | 2016 | 1137 | 0.470 |
Why?
|
Xeroderma Pigmentosum | 1 | 2014 | 3 | 0.470 |
Why?
|
Bipolar Disorder | 1 | 2017 | 254 | 0.460 |
Why?
|
DNA, Satellite | 1 | 2014 | 14 | 0.460 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2014 | 20 | 0.450 |
Why?
|
RNA Processing, Post-Transcriptional | 4 | 2003 | 87 | 0.450 |
Why?
|
Chromosome Mapping | 1 | 2015 | 293 | 0.450 |
Why?
|
HeLa Cells | 8 | 2023 | 527 | 0.450 |
Why?
|
Poliovirus Vaccines | 1 | 2013 | 4 | 0.440 |
Why?
|
Poliomyelitis | 1 | 2013 | 3 | 0.440 |
Why?
|
Alzheimer Disease | 1 | 2019 | 549 | 0.430 |
Why?
|
Symbiosis | 1 | 2013 | 29 | 0.430 |
Why?
|
Eukaryota | 1 | 2013 | 29 | 0.430 |
Why?
|
G2 Phase Cell Cycle Checkpoints | 1 | 2013 | 5 | 0.430 |
Why?
|
Bone Neoplasms | 2 | 2019 | 117 | 0.430 |
Why?
|
Pain | 1 | 2016 | 406 | 0.430 |
Why?
|
DNA Damage | 4 | 2022 | 274 | 0.430 |
Why?
|
Glucose | 1 | 2016 | 444 | 0.420 |
Why?
|
Histocytochemistry | 3 | 2004 | 48 | 0.420 |
Why?
|
DNA, Antisense | 1 | 2012 | 17 | 0.420 |
Why?
|
Biotechnology | 1 | 2012 | 42 | 0.400 |
Why?
|
Active Transport, Cell Nucleus | 3 | 2015 | 106 | 0.400 |
Why?
|
Gene Expression | 4 | 2024 | 805 | 0.400 |
Why?
|
RNA, Small Nuclear | 3 | 2002 | 25 | 0.400 |
Why?
|
Protein Kinases | 1 | 2013 | 139 | 0.400 |
Why?
|
Sequence Analysis, RNA | 1 | 2013 | 151 | 0.400 |
Why?
|
Cell Line, Tumor | 6 | 2016 | 1363 | 0.400 |
Why?
|
GTP-Binding Proteins | 5 | 2014 | 80 | 0.390 |
Why?
|
Gene Editing | 1 | 2016 | 285 | 0.390 |
Why?
|
Advisory Committees | 1 | 2012 | 107 | 0.390 |
Why?
|
Sea Urchins | 2 | 2013 | 35 | 0.380 |
Why?
|
Genetic Therapy | 1 | 2018 | 705 | 0.380 |
Why?
|
Aged, 80 and over | 1 | 2021 | 5062 | 0.380 |
Why?
|
Analgesics, Opioid | 1 | 2016 | 492 | 0.380 |
Why?
|
Television | 1 | 2011 | 22 | 0.380 |
Why?
|
Stress, Physiological | 1 | 2013 | 185 | 0.370 |
Why?
|
Communication | 2 | 2016 | 531 | 0.370 |
Why?
|
Ribonucleoproteins | 4 | 2013 | 112 | 0.370 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 1 | 2010 | 9 | 0.360 |
Why?
|
Bacterial Proteins | 1 | 2016 | 739 | 0.350 |
Why?
|
Tetrahymena | 1 | 2010 | 7 | 0.350 |
Why?
|
Information Dissemination | 1 | 2011 | 114 | 0.350 |
Why?
|
HEK293 Cells | 3 | 2022 | 567 | 0.340 |
Why?
|
Nuclear Envelope | 4 | 2011 | 46 | 0.340 |
Why?
|
DNA Breaks, Single-Stranded | 2 | 2020 | 6 | 0.330 |
Why?
|
Telomerase | 3 | 2006 | 30 | 0.330 |
Why?
|
Inflammation | 1 | 2016 | 1100 | 0.330 |
Why?
|
RNA Transport | 2 | 2006 | 29 | 0.320 |
Why?
|
Opioid-Related Disorders | 1 | 2016 | 465 | 0.320 |
Why?
|
Health Promotion | 1 | 2013 | 490 | 0.320 |
Why?
|
Mutation | 4 | 2018 | 2421 | 0.310 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2008 | 180 | 0.300 |
Why?
|
Medical Staff | 1 | 2008 | 14 | 0.300 |
Why?
|
Actin Cytoskeleton | 1 | 2008 | 75 | 0.290 |
Why?
|
Biological Transport | 8 | 2003 | 289 | 0.290 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 1128 | 0.290 |
Why?
|
China | 2 | 2019 | 141 | 0.290 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2007 | 8 | 0.290 |
Why?
|
G1 Phase | 1 | 2007 | 53 | 0.280 |
Why?
|
Cell Line | 9 | 2020 | 2011 | 0.280 |
Why?
|
Binding Sites | 3 | 2018 | 872 | 0.280 |
Why?
|
Genetic Code | 1 | 2006 | 7 | 0.280 |
Why?
|
Peer Review | 1 | 2007 | 25 | 0.270 |
Why?
|
Physician's Role | 1 | 2008 | 118 | 0.270 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2006 | 72 | 0.270 |
Why?
|
Statistics as Topic | 1 | 2007 | 147 | 0.270 |
Why?
|
Cell Nucleus Structures | 1 | 2005 | 2 | 0.260 |
Why?
|
Microscopy | 1 | 2006 | 88 | 0.260 |
Why?
|
Authorship | 1 | 2006 | 22 | 0.260 |
Why?
|
Centrosome | 1 | 2006 | 71 | 0.260 |
Why?
|
Faculty, Medical | 1 | 2008 | 199 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 483 | 0.250 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 2005 | 57 | 0.240 |
Why?
|
DNA Replication | 3 | 2018 | 229 | 0.240 |
Why?
|
Amino Acids | 1 | 2005 | 140 | 0.240 |
Why?
|
RNA, Nuclear | 3 | 2017 | 13 | 0.230 |
Why?
|
Female | 8 | 2023 | 30715 | 0.230 |
Why?
|
Coiled Bodies | 1 | 2004 | 4 | 0.230 |
Why?
|
Forecasting | 2 | 2016 | 218 | 0.230 |
Why?
|
Histones | 2 | 2020 | 463 | 0.230 |
Why?
|
Base Sequence | 5 | 2016 | 1309 | 0.220 |
Why?
|
Plant Roots | 1 | 2024 | 61 | 0.220 |
Why?
|
Surveys and Questionnaires | 2 | 2022 | 2571 | 0.220 |
Why?
|
Gene Regulatory Networks | 2 | 2016 | 139 | 0.220 |
Why?
|
Green Fluorescent Proteins | 3 | 2016 | 350 | 0.220 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 522 | 0.220 |
Why?
|
Nova Scotia | 1 | 2022 | 2 | 0.210 |
Why?
|
Brain | 1 | 2011 | 1485 | 0.210 |
Why?
|
Cells, Cultured | 6 | 2020 | 2094 | 0.200 |
Why?
|
Alkylating Agents | 1 | 2022 | 9 | 0.200 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 56 | 0.200 |
Why?
|
Mutagens | 1 | 2022 | 19 | 0.200 |
Why?
|
Fluorescent Antibody Technique | 3 | 2013 | 220 | 0.200 |
Why?
|
Ecdysterone | 1 | 2001 | 11 | 0.190 |
Why?
|
Religion | 1 | 2021 | 33 | 0.190 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 122 | 0.190 |
Why?
|
Hormones | 1 | 2001 | 57 | 0.190 |
Why?
|
Trust | 1 | 2021 | 63 | 0.190 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 638 | 0.190 |
Why?
|
Proteome | 1 | 2002 | 135 | 0.180 |
Why?
|
Aerosols | 1 | 2021 | 44 | 0.180 |
Why?
|
Government | 1 | 2020 | 7 | 0.180 |
Why?
|
History, 18th Century | 1 | 2020 | 8 | 0.180 |
Why?
|
Ferns | 1 | 2020 | 1 | 0.180 |
Why?
|
Ascaris | 1 | 2020 | 4 | 0.180 |
Why?
|
Telomere | 2 | 2013 | 47 | 0.180 |
Why?
|
Alternative Splicing | 2 | 2017 | 121 | 0.180 |
Why?
|
Energy Metabolism | 1 | 2003 | 348 | 0.180 |
Why?
|
Molecular Sequence Data | 6 | 2002 | 1972 | 0.180 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2021 | 97 | 0.180 |
Why?
|
Self Concept | 1 | 2020 | 104 | 0.170 |
Why?
|
Nuclear Matrix | 1 | 2000 | 28 | 0.170 |
Why?
|
Central Nervous System Agents | 1 | 2020 | 6 | 0.170 |
Why?
|
Serine-Arginine Splicing Factors | 2 | 2013 | 14 | 0.170 |
Why?
|
Immunogenetics | 1 | 1999 | 4 | 0.170 |
Why?
|
Journalism, Medical | 1 | 2019 | 4 | 0.170 |
Why?
|
Pol1 Transcription Initiation Complex Proteins | 2 | 2014 | 8 | 0.170 |
Why?
|
Insecticides | 1 | 2020 | 29 | 0.170 |
Why?
|
Antibodies, Viral | 1 | 2022 | 305 | 0.170 |
Why?
|
Editorial Policies | 1 | 2020 | 53 | 0.170 |
Why?
|
Blood Coagulation | 1 | 2020 | 50 | 0.170 |
Why?
|
Cancer Care Facilities | 1 | 2019 | 14 | 0.170 |
Why?
|
Xenopus | 1 | 2019 | 53 | 0.170 |
Why?
|
Zoology | 1 | 2019 | 1 | 0.170 |
Why?
|
Ownership | 1 | 2019 | 17 | 0.170 |
Why?
|
Federal Government | 1 | 2019 | 20 | 0.170 |
Why?
|
Illinois | 1 | 2019 | 14 | 0.170 |
Why?
|
Nucleic Acids | 1 | 2020 | 50 | 0.160 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2020 | 77 | 0.160 |
Why?
|
Mosquito Vectors | 1 | 2019 | 11 | 0.160 |
Why?
|
Parasitology | 1 | 2019 | 3 | 0.160 |
Why?
|
Conflict of Interest | 1 | 2019 | 35 | 0.160 |
Why?
|
Anopheles | 1 | 2019 | 17 | 0.160 |
Why?
|
International Cooperation | 1 | 2019 | 84 | 0.160 |
Why?
|
New York | 1 | 2019 | 136 | 0.160 |
Why?
|
Amino Acid Sequence | 2 | 2022 | 1577 | 0.160 |
Why?
|
X-ray Repair Cross Complementing Protein 1 | 1 | 2018 | 1 | 0.160 |
Why?
|
Molecular Structure | 1 | 2020 | 375 | 0.160 |
Why?
|
Oligonucleotide Probes | 4 | 2020 | 43 | 0.160 |
Why?
|
Growth Substances | 1 | 1998 | 35 | 0.160 |
Why?
|
Cloning, Organism | 1 | 2018 | 6 | 0.160 |
Why?
|
A549 Cells | 1 | 2018 | 36 | 0.160 |
Why?
|
Interphase | 1 | 2019 | 66 | 0.160 |
Why?
|
Promyelocytic Leukemia Protein | 1 | 2018 | 16 | 0.160 |
Why?
|
3' Untranslated Regions | 1 | 1999 | 84 | 0.160 |
Why?
|
Plasmids | 3 | 2013 | 279 | 0.160 |
Why?
|
Mutagenesis | 1 | 1999 | 127 | 0.160 |
Why?
|
Influenza Pandemic, 1918-1919 | 1 | 2018 | 1 | 0.160 |
Why?
|
Vitamin B 12 | 1 | 2018 | 25 | 0.150 |
Why?
|
Time Factors | 3 | 2016 | 3554 | 0.150 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 453 | 0.150 |
Why?
|
Women's Rights | 1 | 2018 | 6 | 0.150 |
Why?
|
Universities | 1 | 2019 | 151 | 0.150 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 17 | 0.150 |
Why?
|
Genes, Reporter | 1 | 2018 | 243 | 0.150 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 194 | 0.150 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2017 | 20 | 0.150 |
Why?
|
Societies, Medical | 1 | 2020 | 326 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 40 | 0.150 |
Why?
|
Genetic Engineering | 1 | 2019 | 111 | 0.150 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 418 | 0.150 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 98 | 0.140 |
Why?
|
Microinjections | 3 | 2004 | 65 | 0.140 |
Why?
|
Papillomavirus Vaccines | 1 | 2017 | 71 | 0.130 |
Why?
|
Oligonucleotides | 1 | 1998 | 205 | 0.130 |
Why?
|
California | 1 | 2016 | 160 | 0.130 |
Why?
|
Gluconeogenesis | 1 | 2016 | 15 | 0.130 |
Why?
|
Intelligence | 1 | 2016 | 56 | 0.130 |
Why?
|
RNA Polymerase I | 2 | 2023 | 9 | 0.130 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 427 | 0.130 |
Why?
|
DNA, Ribosomal | 2 | 2010 | 29 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 145 | 0.130 |
Why?
|
Developing Countries | 1 | 2016 | 81 | 0.130 |
Why?
|
Book Reviews as Topic | 1 | 2015 | 2 | 0.130 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 123 | 0.130 |
Why?
|
Philosophy | 1 | 2016 | 12 | 0.130 |
Why?
|
RNA Stability | 1 | 2016 | 92 | 0.130 |
Why?
|
Epithelial Cells | 1 | 1998 | 374 | 0.130 |
Why?
|
Hydrodynamics | 1 | 2015 | 29 | 0.130 |
Why?
|
Genetic Loci | 1 | 2016 | 106 | 0.130 |
Why?
|
Recombinant Fusion Proteins | 3 | 2002 | 500 | 0.130 |
Why?
|
Medicine | 1 | 2016 | 56 | 0.130 |
Why?
|
Cell Differentiation | 2 | 2014 | 1291 | 0.120 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 662 | 0.120 |
Why?
|
Cell Cycle Checkpoints | 1 | 2015 | 44 | 0.120 |
Why?
|
X-Ray Diffraction | 1 | 2014 | 56 | 0.120 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 373 | 0.120 |
Why?
|
Cell Survival | 1 | 2016 | 547 | 0.120 |
Why?
|
Drosophila | 1 | 2017 | 419 | 0.120 |
Why?
|
Oocytes | 2 | 2006 | 189 | 0.120 |
Why?
|
Genetic Diseases, Inborn | 1 | 2014 | 36 | 0.110 |
Why?
|
Puromycin | 1 | 2013 | 5 | 0.110 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 117 | 0.110 |
Why?
|
Anniversaries and Special Events | 1 | 2013 | 14 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 155 | 0.110 |
Why?
|
Dactinomycin | 1 | 2013 | 8 | 0.110 |
Why?
|
Checkpoint Kinase 1 | 1 | 2013 | 8 | 0.110 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2013 | 25 | 0.110 |
Why?
|
Fluorescein | 1 | 2013 | 13 | 0.110 |
Why?
|
Immunohistochemistry | 2 | 2005 | 846 | 0.110 |
Why?
|
Luminescent Proteins | 2 | 2005 | 128 | 0.110 |
Why?
|
Caffeine | 1 | 2013 | 47 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2013 | 83 | 0.100 |
Why?
|
Deoxyribonucleoproteins | 1 | 2012 | 4 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 2 | 2005 | 90 | 0.100 |
Why?
|
Protein Binding | 2 | 2008 | 1542 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2013 | 667 | 0.100 |
Why?
|
Cell Nucleus Division | 1 | 2011 | 2 | 0.100 |
Why?
|
Intranuclear Space | 1 | 2011 | 5 | 0.100 |
Why?
|
Fibroblasts | 2 | 2004 | 366 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 254 | 0.090 |
Why?
|
Writing | 1 | 2011 | 43 | 0.090 |
Why?
|
Neurosciences | 1 | 2011 | 28 | 0.090 |
Why?
|
Speech | 1 | 2011 | 61 | 0.090 |
Why?
|
Phosphorylation | 1 | 2013 | 860 | 0.090 |
Why?
|
Rous sarcoma virus | 1 | 2009 | 3 | 0.090 |
Why?
|
Cell-Free System | 1 | 2009 | 31 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 630 | 0.090 |
Why?
|
Cell Proliferation | 1 | 2014 | 936 | 0.080 |
Why?
|
DNA, Intergenic | 1 | 2009 | 23 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2009 | 57 | 0.080 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2009 | 46 | 0.080 |
Why?
|
Massachusetts | 1 | 2015 | 2082 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2009 | 281 | 0.080 |
Why?
|
Oxidoreductases | 3 | 1973 | 65 | 0.080 |
Why?
|
Diffusion | 2 | 2005 | 84 | 0.070 |
Why?
|
Protein Transport | 1 | 2009 | 393 | 0.070 |
Why?
|
Retinoblastoma Protein | 1 | 2007 | 36 | 0.070 |
Why?
|
ADP-Ribosylation Factors | 1 | 2007 | 20 | 0.070 |
Why?
|
Fund Raising | 1 | 2006 | 7 | 0.070 |
Why?
|
RNA, Messenger, Stored | 1 | 2006 | 5 | 0.070 |
Why?
|
Sweden | 1 | 2006 | 40 | 0.070 |
Why?
|
RNA, Archaeal | 1 | 2006 | 2 | 0.070 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 1 | 2006 | 3 | 0.070 |
Why?
|
Archaea | 1 | 2006 | 9 | 0.070 |
Why?
|
Bivalvia | 1 | 2006 | 20 | 0.070 |
Why?
|
Korea | 1 | 2006 | 3 | 0.070 |
Why?
|
Organizational Innovation | 1 | 2007 | 85 | 0.070 |
Why?
|
Microsomes, Liver | 4 | 1973 | 18 | 0.070 |
Why?
|
Embryo, Nonmammalian | 1 | 2006 | 170 | 0.070 |
Why?
|
Down-Regulation | 1 | 2007 | 304 | 0.070 |
Why?
|
Up-Regulation | 1 | 2007 | 362 | 0.070 |
Why?
|
Microscopy, Electron | 2 | 2005 | 252 | 0.060 |
Why?
|
Leadership | 1 | 2008 | 196 | 0.060 |
Why?
|
Nuclear Pore | 1 | 2005 | 21 | 0.060 |
Why?
|
Phosphorus | 1 | 2005 | 17 | 0.060 |
Why?
|
Nitrogen | 1 | 2005 | 24 | 0.060 |
Why?
|
3T3 Cells | 1 | 2005 | 108 | 0.060 |
Why?
|
Xenopus laevis | 1 | 2005 | 66 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 1092 | 0.060 |
Why?
|
Myosins | 1 | 2006 | 109 | 0.060 |
Why?
|
Light | 1 | 2005 | 201 | 0.060 |
Why?
|
Temperature | 2 | 2004 | 300 | 0.060 |
Why?
|
Cell Division | 1 | 2006 | 441 | 0.060 |
Why?
|
Immunoblotting | 1 | 2005 | 189 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2005 | 116 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2005 | 243 | 0.060 |
Why?
|
Polymers | 1 | 2008 | 315 | 0.060 |
Why?
|
Cricetinae | 2 | 2004 | 376 | 0.060 |
Why?
|
Ribonuclease P | 1 | 2004 | 2 | 0.060 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2004 | 2 | 0.060 |
Why?
|
ran GTP-Binding Protein | 1 | 2004 | 4 | 0.060 |
Why?
|
Primates | 1 | 2004 | 40 | 0.060 |
Why?
|
Stem Cells | 1 | 2006 | 254 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2004 | 64 | 0.060 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2004 | 33 | 0.060 |
Why?
|
Microscopy, Video | 1 | 2003 | 37 | 0.060 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2003 | 3 | 0.060 |
Why?
|
RNA Polymerase III | 1 | 2003 | 9 | 0.060 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2004 | 60 | 0.050 |
Why?
|
Protein Subunits | 1 | 2004 | 162 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 161 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 807 | 0.050 |
Why?
|
Nucleolus Organizer Region | 1 | 2002 | 7 | 0.050 |
Why?
|
Nanotechnology | 1 | 2003 | 128 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2005 | 384 | 0.050 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2001 | 15 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2001 | 18 | 0.050 |
Why?
|
Ecdysone | 1 | 2001 | 15 | 0.050 |
Why?
|
Europe | 1 | 2002 | 182 | 0.050 |
Why?
|
Liver | 2 | 2005 | 781 | 0.050 |
Why?
|
Bacteriophage T7 | 1 | 2001 | 22 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2002 | 156 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 1973 | 203 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2001 | 130 | 0.050 |
Why?
|
Male | 2 | 2015 | 27402 | 0.050 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 32 | 0.050 |
Why?
|
Tissue Fixation | 1 | 2020 | 23 | 0.040 |
Why?
|
Blotting, Western | 1 | 2001 | 592 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2000 | 66 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 192 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 1 | 2020 | 104 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 7 | 0.040 |
Why?
|
Heterochromatin | 1 | 2020 | 84 | 0.040 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 1999 | 12 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 636 | 0.040 |
Why?
|
Viral Proteins | 1 | 2001 | 260 | 0.040 |
Why?
|
Ribonuclease T1 | 1 | 1999 | 3 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1999 | 7 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1999 | 32 | 0.040 |
Why?
|
Ribonuclease, Pancreatic | 1 | 1999 | 11 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 1999 | 97 | 0.040 |
Why?
|
Origin Recognition Complex | 1 | 2018 | 3 | 0.040 |
Why?
|
Antigens, Nuclear | 1 | 2018 | 16 | 0.040 |
Why?
|
Poly (ADP-Ribose) Polymerase-1 | 1 | 2018 | 17 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2000 | 168 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 656 | 0.040 |
Why?
|
Gene Silencing | 1 | 2020 | 377 | 0.040 |
Why?
|
Nucleic Acid Conformation | 1 | 1999 | 231 | 0.040 |
Why?
|
Protein Domains | 1 | 2018 | 138 | 0.040 |
Why?
|
Autoantigens | 1 | 2018 | 125 | 0.040 |
Why?
|
Dogs | 1 | 1998 | 313 | 0.030 |
Why?
|
Computational Biology | 2 | 2013 | 324 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 1999 | 671 | 0.030 |
Why?
|
Databases, Factual | 1 | 1999 | 837 | 0.030 |
Why?
|
Peroxides | 2 | 1972 | 11 | 0.030 |
Why?
|
Oxygen | 2 | 1973 | 307 | 0.030 |
Why?
|
S Phase | 1 | 2014 | 76 | 0.030 |
Why?
|
Xanthine Oxidase | 1 | 1973 | 10 | 0.030 |
Why?
|
Adrenochrome | 1 | 1972 | 1 | 0.030 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 71 | 0.030 |
Why?
|
Epinephrine | 1 | 1972 | 45 | 0.030 |
Why?
|
Mice | 1 | 2005 | 10232 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 1990 | 10 | 0.020 |
Why?
|
Renin | 1 | 1990 | 9 | 0.020 |
Why?
|
Blood Cells | 1 | 1970 | 17 | 0.020 |
Why?
|
Sharks | 1 | 1970 | 7 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1990 | 691 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 1119 | 0.020 |
Why?
|
Cytochrome c Group | 3 | 1973 | 24 | 0.020 |
Why?
|
Cytochrome Reductases | 2 | 1973 | 3 | 0.010 |
Why?
|
Alu Elements | 1 | 2003 | 10 | 0.010 |
Why?
|
Free Radicals | 2 | 1973 | 18 | 0.010 |
Why?
|
NADP | 2 | 1972 | 24 | 0.010 |
Why?
|
Oxidation-Reduction | 2 | 1973 | 303 | 0.010 |
Why?
|
Superoxide Dismutase | 2 | 1973 | 212 | 0.010 |
Why?
|
Poly T | 1 | 1999 | 2 | 0.010 |
Why?
|
Poly A | 1 | 1999 | 27 | 0.010 |
Why?
|
Benzimidazoles | 1 | 1999 | 58 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2003 | 850 | 0.010 |
Why?
|
Deoxycholic Acid | 2 | 1973 | 7 | 0.010 |
Why?
|
Phenobarbital | 2 | 1973 | 13 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1973 | 8 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1973 | 18 | 0.010 |
Why?
|
Benzofurans | 1 | 1973 | 10 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1973 | 65 | 0.010 |
Why?
|
Milk | 1 | 1973 | 50 | 0.010 |
Why?
|
Liposomes | 1 | 1973 | 99 | 0.010 |
Why?
|
Copper | 1 | 1973 | 49 | 0.010 |
Why?
|
Edetic Acid | 1 | 1972 | 23 | 0.010 |
Why?
|
Anaerobiosis | 1 | 1972 | 14 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1972 | 59 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1972 | 89 | 0.010 |
Why?
|
Catalysis | 1 | 1972 | 152 | 0.010 |
Why?
|
Iron | 1 | 1972 | 144 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 1972 | 473 | 0.010 |
Why?
|
Cricetulus | 1 | 1990 | 102 | 0.010 |
Why?
|
Nucleosides | 1 | 1970 | 11 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1990 | 197 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1990 | 384 | 0.010 |
Why?
|
Leucine | 1 | 1970 | 57 | 0.010 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1973 | 3 | 0.000 |
Why?
|
Immunodiffusion | 1 | 1973 | 4 | 0.000 |
Why?
|
Spectrophotometry | 1 | 1973 | 31 | 0.000 |
Why?
|
Membranes | 1 | 1973 | 19 | 0.000 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1973 | 29 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1973 | 50 | 0.000 |
Why?
|
Molecular Weight | 1 | 1973 | 187 | 0.000 |
Why?
|
Solubility | 1 | 1973 | 173 | 0.000 |
Why?
|
Rabbits | 1 | 1973 | 330 | 0.000 |
Why?
|